Fig. 9From: Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor designSequence alignment of the prodomain inhibitory segment for the plasmodial and human cathepsin proteases studied. Marked sequence sections indicate the portions used to design different oligopeptides for docking studies and their conservation as determined by WebLogo server. Actual residue numbering per protein is given on the sideBack to article page